Pfizer has partnered with IBM Watson Health to develop an AI-driven clinical trial platform, which aims to streamline the clinical trial process and reduce costs.
The Partnership
The platform will use machine learning to analyze patient data and identify potential participants for clinical trials.
The platform is expected to reduce clinical trial time by 30%, enabling faster development of new treatments.